Circulating ICAM-1 (sCD54) and LFA-3 (sCD58) in chronic hepatitis B - A longitudinal study in patients treated with interferon-alpha

Zeitschrift fur Gastroenterologie

Volumn 35, Issue 6, 1997, Pages 459-467

  Knolle, P A ^a   Eckardt, A J ^a   Protzer Knolle, U ^a   Schirmacher, P ^a   Dienes, H P ^a   Meyer Zum Buschenfelde K H ^a   Gerken, G ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Intercellular adhesion molecule I; Liver function; Lymphocyte function associated antigen 3; Soluble adhesion molecules

Indexed keywords

ALPHA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3;

ADULT; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; DATA ANALYSIS; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFECT; HEPATITIS B; HUMAN; LIVER FUNCTION; LONGITUDINAL STUDY;

ADULT; AGED; ANTIGENS, CD58; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS, CHRONIC; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON-ALPHA; LIVER FUNCTION TESTS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED;

EID: 0030855183     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Montano L, Aranguibel F, Boffill M et al. Goodall AH, Janossy G and Thomas HC. An analysis of the composition of the inflammatory infiltrate in autoimmune and hepatitis B virus induced chronic liver disease. Hepatology 1983; 3: 292-6
2. Volpes R, van den Oord JJ, Desmet VJ. Memory T cells represent the predominant lymphocyte subset in acute and chronic liver inflammation. Hepatology 1991; 13: 826-9
3. Autschbach F, Meuer SC, Moebius U et al. Hepatocellular expression of lymphocyte-function-associated-antigen 3 in chronic hepatitis. Hepatology 1991; 14: 223-30
4. Dienes HP, Hütteroth T, Hess G, Meuer SC. Immunoelectron microscopic observations on the inflammatory infiltrates and HLA antigens in hepatitis B and non-A. non-B. Hepatology 1987; 7: 1317-25
5. Meuer SC, Moebius U, Manns HP et al. Clonal analysis of human T lymphocytes infiltrating the liver in chronic active hepatitis B and primary biliary cirrhosis. Eur J Immunol 1988; 18: 1447-52
6. Löhr HF, Schlaak JF, Gerken G et al. K-II. Phenotypical analysis and cytokine release of liver-infiltrating and peripheral blood T lymphocytes from patients with chronic hepatitis of different etiology. Liver 1994; 14: 161-6
7. Sanchez-Madrid F, Krensky AM, Ware CF et al. Three distinct antigens associated with human T-lymphocyte-mediated cytolysis: LFA-1, LFA-2 and LFA-3. Proc Natl Acad Sci 1982; 79: 7489-93
8. Siliciano RF, Pratt JC, Schmidt RE, Ritz J, Reinherz EL. Activation of cytolytic T lymphocyte and natural killer cell function through the T11 sheep erythrocyte binding protein. Nature 1985; 317: 428-30
9. Scoazec JY, Feldmann G. The cell adhesion molecules of hepatic sinusoidal endothelial cells. J Hepatol 1994; 20 (2): 296-300
10. Volpes R, van den Oord J, Desmet VJ. Immunohistochemical study of adhesion molecules in liver inflammation. Hepatology 1990; 12 (1): 59-65
11. Rothlein R, Mainolfi EA, Czajkowski M, Marlin SD. A form of circulating ICAM-1 in human serum. J Immunol 1991; 147 (11): 3788-93
12. Jander S, Heidenreich F, Stoll G. Serum and CSF levels of soluble intercellular adhesion molecule-1 (ICAM-1) in inflammatory neurologic diseases. Neurology 1993; 43 (9): 1809-13
13. Hoffmann JC, Dengler TJ, Knolle PA et al. A soluble form of the adhesion receptor CD58 (LFA-3) is present in human body fluids. Eur J Immunol 1993; 23: 3003-10
14. Hoffmann JC, Autschbach F, Rensch K et al. Cytokine stimulation augments the release of soluble CD58 from various human cell lines. Immunobiology 1992; 186: 133 (abstract)
15. Rieckmann P, Michel U, Albrecht M et al. Cerebral endothelial cells are a major source for soluble intercellular adhesion molecule-1 in the human central nervous system. Neurosci Lett 1995; 186 (1): 61-4
16. Albert-Wolf M, Meuer SC, Wallich R. Dual function of recombinant human CD58: Inhibition of T cell adhesion and activation via the CD2 pathway. Int Immunol 1991; 3: 1335-47
17. Becker JC, Termeer C, Schmidt RE, Brocker EB. Soluble intercellular adhesion molecule-1 inhibits MHC-restricted specific T cell/tumor interaction. J Immunol 1993; 151 (12): 7224-32
18. Rieckmann P, Michel U, Albrecht M et al. Soluble forms of intercellular adhesion molecule-1 (ICAM-1) block lymphocyte attachment to cerebral endothelial cells. J Neuroimmunol 1995; 60 (1-2): 9-15
19. Lim AG, Jazrawi RP, Ahmed HA et al. Soluble intercellular adhesion molecule-1 in primary biliary cirrhosis: Relationship with disease stage, immune activity and cholestasis. Hepatology 1994; 20: 882-8
20. Horiike N, Onji M, Kumamoto I, Masumoto T. Soluble intercellular adhesion molecule-1 in serum in chronic hepatitis B and C. J Gastroenterol 1994; 29 (4): 455-9
21. Hyodo I, Jinno K, Tanimizu M et al. Detection of circulating intercellular adhesion molecule-1 in hepatocellular carcinoma. Int J Cancer 1993; 55 (5): 775-9
22. Jones SC, Banks RE, Haidar A et al. Adhesion molecules in inflammatory bowel disease. Gut 1995; 36 (5): 724-30
23. Wolff JM, Stephenson RN, Chisholm GD, Habib FK. Levels of circulating intercellular adhesion molecule-1 in patients with metastatic cancer of the prostate and benign prostatic hyperplasia. Eur J Cancer 1995; 31 A: 339-41
24. Jakobsen PH, Morris JS, Ronn A et al. Increased plasma concentrations of sICAM-1, sVCAM-1 and sELAM-1 in patients with Plasmodium falciparum or P. vivax malaria and association with disease severity. Immunology 1994; 83 (4): 665-9
25. Mrowka C, Sieberth HG. Circulating adhesion molecules ICAM-1, VCAM-1 and E-selectin in systemic vasculitis: Marked differences between Wegener's granulomatosis and systemic lupus erythematosus. Clin Investig 1994; 72 (10): 762-8
26. Spronk PE, Bootsma H, Huitema MG, Limburg PC, Kallenberg CG. Levels of soluble VCAM-1, soluble ICAM-1, and soluble E-selectin during disease exacerbations in patients with systemic lupus erythematosus (SLE); a long-term prospective study. Clin Exp Immunol 1994; 97 (3): 439-44
27. Schopf RE, Naumann S, Rehder M, Morsches B. Soluble intercellular adhesion molecule-1 levels in patients with psoriasis. Br J Dermatol 1993; 128 (1): 34-7
28. Harning R, Mainolfi E, Bystryn JC et al. Serum levels of circulating intercellular adhesion molecule 1 in human malignant melanoma. Cancer Res 1991; 51 (18): 5003-5
29. Steinhoff G, Behrend M, Schrader B, Duijvestijn AM, Wonigeit K. Expression patterns of leukocyte adhesion ligand molecules on human liver endothelial. Lack of ELAM-1 and CD62 inducibility on sinusoidal endothelia and distinct distribution of VCAM-1, ICAM-1, ICAM-2, and LFA-3. Am J Pathol 1993; 142: 481-8
30. Volpes R, van den Oord J, Desmet VJ. Hepatic expression of intercellular adhesion molecule-1 (ICAM-1) in viral hepatitis B. Hepatology 1990; 12 (1): 148-54
31. Hoffmann JC, Bahr MJ, Tietge UF et al. Detection of a soluble form of the human adhesion receptor lymphocyte function-associated-antigen-3 (LFA-3) in patients with chronic liver disease. J Hepatol 1996; 25: 465-73
32. Adams DH, Mainolfi E, Burra P et al. Detection of circulating intercellular adhesion molecule-1 in chronic liver diseases. Hepatology 1992; 16 (3): 810-4
33. Nouri AK, Koskinas J, Tibbs CJ, Portmann BC, Williams R. Serum intercellular adhesion molecule1 levels in chronic hepatitis C: association with disease activity and response to interferon α. Gut 1995; 36 (4): 599-603
34. Adams DH, Mainolfi E, Elias E, Neuberger JM, Rothlein R. Detection of circulating intercellular adhesion molecule-1 after liver transplantation evidence of local release within the liver during graft rejection. Transplantation 1993; 55 (1): 83-7
35. Zöhrens G, Armbrust T, Pirzer U, Meyer zum Büschenfelde K-H, Ramadori G. Intercellular adhesion molecule-1 concentration in sera of patients with acute and chronic liver disease: Relationship to disease activity and cirrhosis. Hepatology 1993; 18: 798-802
36. Christensen JP, Johansen J, Marker O, Thomsen AR. Circulating intercellular adhesion molecule-1 (ICAM-1) as an early and sensitive marker for virus-induced T cell activation. Clin Exp Immunol 1995; 102 (2): 268-73
37. Hu K-Q, Yu CH, Vierling JM. Upregulation of intercellular adhesion molecule 1 transcription by hepatitis B virus X protein. Proc Natl Acad Sci 1992; 89: 11441-45
38. Polzien F, Ramadori G. Increased intercellular adhesion molecule-1 serum concentration in cholestasis. J Hepatol 1996; 25: 877-86
39. Pirisi M, Falleti E, Fabris C et al. Circulating intercellular adhesion molecule-1 (cICAM-1) concentration in liver disease. Relationship with cholestasis and functioning hepatic mass. Am J Clin Pathol 1994; 102 (5): 600-4